【摘要】 目的：探讨宣肺补益汤联合西药治疗慢性阻塞性肺疾病急性加重期患者的效果。方法：將2021年6月—2022年6月宜春学院第二附属医院内三科收治的60例慢性阻塞性肺疾病急性加重期患者作为研究对象。采取随机数字表法分为对照组和观察组，各30例。对照组接受西药治疗，观察组在对照组基础上加用宣肺补益汤。比较两组的治疗效果及入院时、治疗后的中医症候评分、肺功能、血气分析指标检测结果的变化情况。结果：观察组总有效率为96.67%，高于对照组的80.00%，差异有统计学意义(P1)、FEV₁与用力肺活量(FVC)比值(FEV₁/FVC%)、最大呼气流量(PEF)均高于对照组，差异均有统计学意义(P2)、动脉血氧饱和度(SaO₂)均高于对照组，动脉血二氧化碳分压(PaCO₂)低于对照组，差异均有统计学意义(P1)， the ratio of FEV₁to forced vital capacity (FVC) (FEV₁/FVC%) and the peak expiratory flow (PEF) in the observation group were higher than those in the control group， the differences were statistically significant (P2) and arterial oxygen saturation (SaO₂) in the observation group were higher than those in the control group ......